Development Options Sample Clauses

Development Options. 6.1 The development options for various parts of the works proposed in the Assignment are assessed taking into consideration the design requirement, site constraints and generation of C&D material.
AutoNDA by SimpleDocs
Development Options. As the Stage 1 PEP had already gathered views from the stakeholders and the public on their aspirations and visions on how to enhance the harbour-front, the consultants should prepare more options for each PDS for public consultation at the Stage 2 PEP. - Apart from the proposed waterfront promenade with cafés and restaurants, the consultants should come up with more innovative land use proposals and options (e.g. more variations in the design of the promenade and disposition of buildings) in the District Plan for the public to comment and choose. Simply presenting them with a recommended option was not adequate. - To enable a meaningful discussion and consultation with the public at the Stage 2 PEP, the consultants should provide more detailed information on their assessment of different options of each PDS before coming up with the recommended land use proposals. Preparation of 3-D digital models, photomontages and relevant graphic presentations showing different options would be helpful in this regard.
Development Options. A6.6.1.1 The construction activities including the site formation and foundation works at the proposed expanded and upgraded San Wai STW and the expanded Ha Tsuen Pumping Station will generate C&D material. At present, a portion of the expanded site of San Wai STW is fishponds, while the remainder is being used as container storage yards.
Development Options. TERRANORTE, hereby, in consideration of the payment of Twenty-Eight Thousand Reais (RS $28,000), to be paid on the terms and conditions following below, grants to Equatorial the option to elect one or more of the following two options regarding the development of its properties:
Development Options. (i) As set forth in this Agreement, "

Related to Development Options

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!